Total Funding
64
68
Total FundingGrant raised
Growth Score
-25 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
113641
Transforming Diagnostics and Drug Discovery
- John Gillespie: President and CEO
- Kenneth Rothschild: Founder, Executive Chairman, and Chief Innovation Officer
About the Company
At AmberGen, we create and market technologies and services that enable drug developers, disease researchers, and physicians to obtain several orders of magnitude greater spatially-resolved information across a wide spectrum of different classes of biomarkers from precious bio-samples, such as biopsies which was previously not possible.
